Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein

被引:96
作者
Raghuwanshi, Dharmendra [1 ]
Mishra, Vivek [1 ]
Das, Dipankar [1 ]
Kaur, Kamaljit [1 ]
Suresh, Mavanur R. [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Dent Pharm Ctr 3126, Edmonton, AB T6G 2N8, Canada
基金
美国国家卫生研究院;
关键词
dendritic cells; DEC-205; receptor; chitosan nanoparticles; bifunctional fusion protein; low-dose vaccines; ACUTE RESPIRATORY SYNDROME; IN-VIVO; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; RECEPTOR DEC-205; CORONAVIRUS; VACCINE; MICE; MECHANISM; DELIVERY;
D O I
10.1021/mp200553x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This work investigates the formulation and in vivo efficacy of dendritic cell (DC) targeted plasmid DNA loaded biotinylated chitosan nanoparticles for nasal immunization against nucleocapsid (N) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) as antigen. The induction of antigen-specific mucosal and systemic immune response at the site of virus entry is a major challenge for vaccine design. Here, we designed a strategy for noninvasive receptor mediated gene delivery to nasal resident DCs. The pDNA loaded biotinylated chitosan nanoparticles were prepared using a complex coacervation process and characterized for size, shape, surface charge, plasmid DNA loading and protection against nuclease digestion. The pDNA loaded biotinylated chitosan nanoparticles were targeted with bifunctional fusion protein (bfFp) vector for achieving DC selective targeting. The bfFp is a recombinant fusion protein consisting of truncated core-streptavidin fused with anti-DEC-205 single chain antibody (scFv). The core-streptavidin arm of fusion protein binds with biotinylated nanoparticles, while anti-DEC-205 scFv imparts targeting specificity to DC DEC-205 receptor. We demonstrate that intranasal administration of bfFp targeted formulations along with anti-CD40 DC maturation stimuli enhanced magnitude of mucosal IgA as well as systemic IgG against N protein. The strategy led to the detection of augmented levels of N protein specific systemic IgG and nasal IgA antibodies. However, following intranasal delivery of naked pDNA no mucosal and systemic immune responses were detected. A parallel comparison of targeted formulations using intramuscular and intranasal routes showed that the intramuscular route is superior for induction of systemic IgG responses compared with the intranasal route. Our results suggest that targeted pDNA delivery through a noninvasive intranasal route can be a strategy for designing low-dose vaccines.
引用
收藏
页码:946 / 956
页数:11
相关论文
共 43 条
[1]   Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638
[2]   In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination [J].
Bonifaz, LC ;
Bonnyay, DP ;
Charalambous, A ;
Darguste, DI ;
Fujii, SI ;
Soares, H ;
Brimnes, MK ;
Moltedo, B ;
Moran, TM ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06) :815-824
[3]   Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles [J].
Corsi, K ;
Chellat, F ;
Yahia, L ;
Fernandes, JC .
BIOMATERIALS, 2003, 24 (07) :1255-1264
[4]   Nanoparticles for nasal vaccination [J].
Csaba, Noemi ;
Garcia-Fuentes, Marcos ;
Alonso, Maria Jose .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (02) :140-157
[5]   Copious production of SARS-CoV nucleocapsid protein employing codon optimized synthetic gene [J].
Das, Dipankar ;
Suresh, Mavanur R. .
JOURNAL OF VIROLOGICAL METHODS, 2006, 137 (02) :343-346
[6]   Identification of a novel coronavirus in patients with severe acute respiratory syndrome [J].
Drosten, C ;
Günther, S ;
Preiser, W ;
van der Werf, S ;
Brodt, HR ;
Becker, S ;
Rabenau, H ;
Panning, M ;
Kolesnikova, L ;
Fouchier, RAM ;
Berger, A ;
Burguière, AM ;
Cinatl, J ;
Eickmann, M ;
Escriou, N ;
Grywna, K ;
Kramme, S ;
Manuguerra, JC ;
Müller, S ;
Rickerts, V ;
Stürmer, M ;
Vieth, S ;
Klenk, HD ;
Osterhaus, ADME ;
Schmitz, H ;
Doerr, HW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1967-1976
[7]   Molecular mechanism and function of CD40/CD40L engagement in the immune system [J].
Elgueta, Raul ;
Benson, Micah J. ;
de Vries, Victor C. ;
Wasiuk, Anna ;
Guo, Yanxia ;
Noelle, Randolph J. .
IMMUNOLOGICAL REVIEWS, 2009, 229 :152-172
[8]  
Garg Neeraj K, 2010, Recent Pat Drug Deliv Formul, V4, P114
[9]   SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens [J].
Gupta, V ;
Tabiin, TM ;
Sun, K ;
Chandrasekaran, A ;
Anwar, A ;
Yang, K ;
Chikhlikar, P ;
Salmon, J ;
Brusic, V ;
Marques, ETA ;
Kellathur, SN ;
August, TJ .
VIROLOGY, 2006, 347 (01) :127-139
[10]   TISSUE DISTRIBUTION OF THE DEC-205 PROTEIN THAT IS DETECTED BY THE MONOCLONAL-ANTIBODY NLDC-145 .1. EXPRESSION ON DENDRITIC CELLS AND OTHER SUBSETS OF MOUSE LEUKOCYTES [J].
INABA, K ;
SWIGGARD, WJ ;
INABA, M ;
MELTZER, J ;
MIRZA, A ;
SASAGAWA, T ;
NUSSENZWEIG, MC ;
STEINMAN, RM .
CELLULAR IMMUNOLOGY, 1995, 163 (01) :148-156